JP2007523176A5 - - Google Patents

Download PDF

Info

Publication number
JP2007523176A5
JP2007523176A5 JP2006554214A JP2006554214A JP2007523176A5 JP 2007523176 A5 JP2007523176 A5 JP 2007523176A5 JP 2006554214 A JP2006554214 A JP 2006554214A JP 2006554214 A JP2006554214 A JP 2006554214A JP 2007523176 A5 JP2007523176 A5 JP 2007523176A5
Authority
JP
Japan
Prior art keywords
active ingredient
citalopram
polymorph
solvate
hydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006554214A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007523176A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/005111 external-priority patent/WO2005079787A1/en
Publication of JP2007523176A publication Critical patent/JP2007523176A/ja
Publication of JP2007523176A5 publication Critical patent/JP2007523176A5/ja
Withdrawn legal-status Critical Current

Links

JP2006554214A 2004-02-17 2005-02-17 シタロプラム、エスシタロプラム又はシタロプラム代謝物質を用いる片頭痛又は頭痛疾患の治療又は病気の予防法 Withdrawn JP2007523176A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54571004P 2004-02-17 2004-02-17
PCT/US2005/005111 WO2005079787A1 (en) 2004-02-17 2005-02-17 Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites

Publications (2)

Publication Number Publication Date
JP2007523176A JP2007523176A (ja) 2007-08-16
JP2007523176A5 true JP2007523176A5 (https=) 2008-05-08

Family

ID=34886186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006554214A Withdrawn JP2007523176A (ja) 2004-02-17 2005-02-17 シタロプラム、エスシタロプラム又はシタロプラム代謝物質を用いる片頭痛又は頭痛疾患の治療又は病気の予防法

Country Status (6)

Country Link
US (1) US7714023B2 (https=)
EP (1) EP1720541A1 (https=)
JP (1) JP2007523176A (https=)
AU (1) AU2005215790A1 (https=)
CA (1) CA2556424A1 (https=)
WO (1) WO2005079787A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10086026B2 (en) * 2016-06-27 2018-10-02 Uwais M. Syed Combined herbal and pharmaceutical composition and method
KR102331187B1 (ko) * 2019-04-09 2021-11-26 주식회사 라이트팜텍 에스시탈로프람을 함유하는 안정성이 우수한 경구용 액제 조성물 및 그의 제조방법
WO2023101866A1 (en) * 2021-12-01 2023-06-08 Zogenix International Limited Fenfluramine for treatment of conditions associated with spreading depolarization

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076461A1 (en) 2001-03-26 2002-10-03 Serdar Murat Dursun Combination of reboxetine and citalopram
US20050014848A1 (en) * 2002-01-23 2005-01-20 Pfizer Inc. Combination of serotonin reuptake inhibitors and norephinephrine reuptake inhibitors
WO2003072138A1 (en) 2002-02-26 2003-09-04 Ortho-Mcneil Pharmaceutical Inc. Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
GB2392385A (en) 2002-09-02 2004-03-03 Cipla Ltd Pharmaceutical preparations comprising a 5HT uptake inhibitor and a homopolymer or copolymer of N-vinyl pyrrolidone

Similar Documents

Publication Publication Date Title
JP2013544850A5 (https=)
JP2005515966A5 (https=)
JP2003521470A5 (https=)
JP2015083580A5 (https=)
JP2014516942A5 (https=)
JP2015515985A5 (https=)
JP2013541583A5 (https=)
JP2019535760A5 (ja) ガボキサドールを用いた注意欠陥多動性障害(adhd)の治療方法
ME02474B (me) Terapijski režimi
JP2014508758A5 (https=)
JP2019518022A5 (https=)
JP2013536837A5 (https=)
JP2009517411A5 (https=)
JP2003504332A5 (https=)
RU2008134143A (ru) Фармацевтическая композиция цитиколина, холина альфосцерата и l-карнитина (или ацетил-l-карнитина) для лечения и профилактики заболеваний центральной нервной системы и способ лечения
JP2005533830A (ja) トロンボキサンa2受容体アンタゴニストおよびcox−2阻害剤の薬剤の組み合わせ
JP2005533830A5 (https=)
JP2011519873A5 (https=)
JP2017533956A (ja) 筋肉痛を含む病態の治療のための組合せ
JP2005519936A5 (https=)
JP2007523176A5 (https=)
JP2021066751A (ja) 経口用医薬組成物
JP2021530568A5 (https=)
JP2017511307A5 (https=)
JP2019514978A5 (https=)